Dr. Parnetti and Dr. Chiasserini contributed equally to this work.
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
Version of Record online: 16 JAN 2014
© 2014 The Authors. International Parkinson and Movement Disorder Society published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Volume 29, Issue 8, pages 1019–1027, July 2014
How to Cite
Parnetti, L., Chiasserini, D., Persichetti, E., Eusebi, P., Varghese, S., Qureshi, M. M., Dardis, A., Deganuto, M., De Carlo, C., Castrioto, A., Balducci, C., Paciotti, S., Tambasco, N., Bembi, B., Bonanni, L., Onofrj, M., Rossi, A., Beccari, T., El-Agnaf, O. and Calabresi, P. (2014), Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease. Mov. Disord., 29: 1019–1027. doi: 10.1002/mds.25772
Funding agencies: Michael J. Fox Foundation for Parkinson's Research (Rapid Response Innovation Awards: CSF Lysosomal Hydrolases' Activity as Possible Marker of Parkinson's Disease, 2010-2011; Validation of Lysosomal Enzymes Assay in CSF, 2011-2012); Fondazione Cassa di Risparmio di Perugia (2013-0274.021).
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 17 JUL 2014
- Version of Record online: 16 JAN 2014
- Manuscript Accepted: 12 NOV 2013
- Manuscript Revised: 4 NOV 2013
- Manuscript Received: 27 FEB 2013
Additional supporting information may be found in the online version of this article at the publisher's web-site.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.